Skip to main content
    RT @drdavidliew: Just so good to see PMR on the plenary stage at #ACR22, after #EULAR2022 too

    SAPHYR study: sarilumab a
    1 year 4 months ago
    Just so good to see PMR on the plenary stage at #ACR22, after #EULAR2022 too SAPHYR study: sarilumab allows for - a quicker steroid wean & less toxicity - but also far more disease remission, quicker symptom resolution, better quality of life Game-changing. ABST1676 @RheumNow https://t.co/ZVqlMNoniu https://t.co/Fv3VRZrKGe
    RT @doctorRBC: Study shows no progressive increase of MRI structural lesions in SI joints of health individuals with inc
    1 year 4 months ago
    Study shows no progressive increase of MRI structural lesions in SI joints of health individuals with increasing age, including: Bone marrow edema, erosions, fat lesions Abs#2258 @RheumNow #ACR22 https://t.co/W2dkRCAPc4
    RT @synovialjoints: Updated ACR Guidelines on Prevention and Rx of GIOP

    Rx recommendations when new fractures occur aft
    1 year 4 months ago
    Updated ACR Guidelines on Prevention and Rx of GIOP Rx recommendations when new fractures occur after 12 months of initial OP Rx https://t.co/TWdI728pCp Mary Beth Humphrey #ACR22 @RheumNow https://t.co/wHANvymd5R
    RT @synovialjoints: Updated ACR Guidelines on Prevention and Rx of GIOP

    OP Rx in special populations

    https://t.co/TWdI
    1 year 4 months ago
    Updated ACR Guidelines on Prevention and Rx of GIOP OP Rx in special populations https://t.co/TWdI728XrX Mary Beth Humphrey #ACR22 @RheumNow https://t.co/0h72a4jXmG
    RT @KDAO2011: #CurbsideConsult. What would you do? 45 yo female with dSSc and ILD, had been on stable MMF 1500 mg bid. s
    1 year 4 months ago
    #CurbsideConsult. What would you do? 45 yo female with dSSc and ILD, had been on stable MMF 1500 mg bid. she had increased SOB, new dry cough, hand pain, stiffness.Exam noted synovitis, Labs: ESR 76, Echo RSVP 25 mmHg, HRCT increased ILD compared to a year ago. #ACR22 @rheumnow
    RT @RichardPAConway: Abdel-Wahab et al. TCZ in combo with ipilimumab/nivolumab. Very preliminary results of what will be
    1 year 4 months ago
    Abdel-Wahab et al. TCZ in combo with ipilimumab/nivolumab. Very preliminary results of what will be important trial. Appears safe and well-tolerated with no increased risk cancer progression. @RheumNow #ACR22 Abstr#1670 https://t.co/uPBnHJ9BRH
    RT @uptoTate: SAPHYR results: SAR + 14 wk GC taper showed efficacy vs comparator arm in steroid refractory PMR, includin
    1 year 4 months ago
    SAPHYR results: SAR + 14 wk GC taper showed efficacy vs comparator arm in steroid refractory PMR, including clinically meaningful improvement in QoL. No new safety signals. Plenary Abs 1676 #ACR22 @RheumNow https://t.co/mHu3e9JbCp https://t.co/93kbczSTfS
    RT @ericdeinmd: Ab1672 #ACR22 SSc on Women's Health
    100 pts - 75% lSSc
    59% sexuality aff by SSc (vag dryness 67%, dig ul
    1 year 4 months ago
    Ab1672 #ACR22 SSc on Women's Health 100 pts - 75% lSSc 59% sexuality aff by SSc (vag dryness 67%, dig ulcers 37%, GI 37%, dyspnea 20%) 48 pts dx during repro ys - 73% never discuss contraception, 30% didn't reach family plan 22 pt - 43 pregn, 33 birth: C-sxn, low bth wt @Rheumnow https://t.co/JRkyCVEXLB
    RT @StevenEchard: More than 25,000 #ACR22 tweets since November 1 - keep going strong today and we will reach 100,000,00
    1 year 4 months ago
    More than 25,000 #ACR22 tweets since November 1 - keep going strong today and we will reach 100,000,000 impressions. Congrats to @rheum_cat, @RheumNow and @CreakyJoints for having the most impact with over 10M impressions each. @ACRheum @StevenEchard https://t.co/K2Kr4sAicS